786 A randomized, double blind, placebo controlled phase II trial to evaluate the safety and efficacy of recMAGE-A3 + AS15 antigen specific cancer immunotherapy in patients with MA... von Mulders, P.F.A, Colombel, M, Heidenreich, A, Martínez-Piñeiro, L, Babjuk, M, Korneyev, I, Surcel, C, Yakovlev, P, Colombo, R, Radziszewski, P, Witjes, J.A, Schipper, R, Witjes, W.P.J, Steering Committee Magnolia

Volltext